Efficacy and Safety of Alemtuzumab Versus Fingolimod in RRMS after Natalizumab Cessation
Journal of neurology(2018)
Key words
Alemtuzumab,Natalizumab,Fingolimod,Remitting-relapsing multiple sclerosis,Progressive multifocal leukoencephalopathy,Immunomodulatory therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined